These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28457961)

  • 41. Design and optimization of PLGA microparticles for controlled and local delivery of Neuregulin-1 in traumatic spinal cord injury.
    Santhosh KT; Alizadeh A; Karimi-Abdolrezaee S
    J Control Release; 2017 Sep; 261():147-162. PubMed ID: 28668379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin.
    Nan K; Ma F; Hou H; Freeman WR; Sailor MJ; Cheng L
    Acta Biomater; 2014 Aug; 10(8):3505-12. PubMed ID: 24793657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled delivery of antibodies from injectable hydrogels.
    Fletcher NA; Babcock LR; Murray EA; Krebs MD
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():801-806. PubMed ID: 26652435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection.
    Fargnoli AS; Mu A; Katz MG; Williams RD; Margulies KB; Weiner DB; Yang S; Bridges CR
    J Transl Med; 2014 Jun; 12():171. PubMed ID: 24934216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel preparation method for sustained-release PLGA microspheres using water-in-oil-in-hydrophilic-oil-in-water emulsion.
    Hong X; Wei L; Ma L; Chen Y; Liu Z; Yuan W
    Int J Nanomedicine; 2013; 8():2433-41. PubMed ID: 23882140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microparticles produced by the hydrogel template method for sustained drug delivery.
    Lu Y; Sturek M; Park K
    Int J Pharm; 2014 Jan; 461(1-2):258-69. PubMed ID: 24333903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
    Leelakanok N; Geary SM; Salem AK
    J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
    Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
    Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.
    Yamaguchi Y; Takenaga M; Kitagawa A; Ogawa Y; Mizushima Y; Igarashi R
    J Control Release; 2002 Jun; 81(3):235-49. PubMed ID: 12044564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application.
    Wu XS
    Artif Cells Blood Substit Immobil Biotechnol; 2004; 32(4):575-91. PubMed ID: 15974184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
    Nair K L; Jagadeeshan S; Nair SA; Kumar GS
    Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
    Li Z; Xiong F; He J; Dai X; Wang G
    Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres.
    Xu FH; Zhang Q
    Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: in vitro characterization and application in polycaprolactone fumarate nerve conduits.
    Rui J; Dadsetan M; Runge MB; Spinner RJ; Yaszemski MJ; Windebank AJ; Wang H
    Acta Biomater; 2012 Feb; 8(2):511-8. PubMed ID: 22019759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
    Blanco D; Alonso MJ
    Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: a promising approach for the treatment of defective telomerase disorders.
    Egusquiaguirre SP; Manguán-García C; Pintado-Berninches L; Iarriccio L; Carbajo D; Albericio F; Royo M; Pedraz JL; Hernández RM; Perona R; Igartua M
    Eur J Pharm Biopharm; 2015 Apr; 91():91-102. PubMed ID: 25660910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Three-dimensional poly(lactic-co-glycolic acid)/silica colloidal crystal microparticles for sustained drug release and visualized monitoring.
    Guo R; Sun XT; Zhang Y; Wang DN; Yang CG; Xu ZR
    J Colloid Interface Sci; 2018 Nov; 530():465-472. PubMed ID: 29990782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A synthetic polymer matrix for the delayed or pulsatile release of water-soluble peptides.
    Schachter DM; Kohn J
    J Control Release; 2002 Jan; 78(1-3):143-53. PubMed ID: 11772456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.